Lukas van de Sand
- Pharmacology top 5%
- Infectious Diseases
- Complementary and alternative medicine top 5%
- Molecular Biology
- Immunology
- Co-authors
- Adalbert KrawczykOliver WitzkeMaren BormannChristiane Silke HeilinglohUlf DittmerMira AltLeonie SchipperEike Steinmann
- Topics
- SARS-CoV-2 and COVID-19 Research (5 papers)COVID-19 Clinical Research Studies (4 papers)Pneumocystis jirovecii pneumonia detection and treatment (2 papers)
- Partner nations
- Germany
In The Last Decade
Lukas van de Sand
11 papers receiving 285 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Pharmacology 98
- Infectious Diseases 79
- Complementary and alternative medicine 73
- Molecular Biology 58
- Immunology 41
Countries citing papers authored by Lukas van de Sand
This map shows the geographic impact of Lukas van de Sand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas van de Sand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas van de Sand more than expected).
Fields of papers citing papers by Lukas van de Sand
This network shows the impact of papers produced by Lukas van de Sand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas van de Sand. The network helps show where Lukas van de Sand may publish in the future.
Co-authorship network of co-authors of Lukas van de Sand
This figure shows the co-authorship network connecting the top 25 collaborators of Lukas van de Sand. A scholar is included among the top collaborators of Lukas van de Sand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas van de Sand. Lukas van de Sand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 10 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | 9 | |
| 10 | 25 | |
| 11 | Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Proteasebreakdown → | 139 |
| 12 | 49 | |
| 13 | 3 | |
| 14 | 39 |
About Lukas van de Sand
Lukas van de Sand is a scholar working on General Dentistry, Transplantation and Infectious Diseases, having authored 14 papers that have together received 291 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Pharmacology (98 citations), Complementary and alternative medicine (73 citations) and Molecular Medicine (27 citations). Lukas van de Sand has collaborated with scholars based in Germany. Frequent co-authors include Adalbert Krawczyk, Oliver Witzke, Maren Bormann, Christiane Silke Heilingloh, Ulf Dittmer, Mira Alt, Leonie Schipper, Eike Steinmann, Carina Elsner and Daniel Tödt. Their work appears in journals such as Frontiers in Immunology, mBio and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.